Reticular (YC F24, MIT)
- Biotech or pharma, therapeutic R&D
- Digital health
- Supplier, engineering
- CMO, CRO
Reticular helps derisk early-stage drug programs by collecting relevant human genetic evidence 100x cheaper & efficiently than biobanks by employing AI-powered phenotypic screening at scale.
Founded by MIT alums. Backed by Y-Combinator and Charles River Ventures.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}